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Abstract
Background and aims
With the intention to gain support for the hypothesis that incident ischemic complications of
atherosclerotic disease involve a stochastic aspect, we performed a histological, qualitative
evaluation of the epidemiology of coronary atherosclerotic disease in a cohort of aortic valve
donors.
Patients and methods
Donors (n = 695, median age 54, range 11–65 years) were dichotomized into a non-cardio-
vascular (non-CVD) and a cardiovascular disease death (CVD) group. Consecutive 5 mm
proximal left coronary artery segments were Movat stained, and the atherosclerotic burden
for each segment was graded (revised AHA-classification).
Results
Non-CVD and CVD groups showed steep increase of atherosclerosis severity beyond the
age of 40, resulting in an endemic presence of advanced atherosclerosis in men over 40
and women over 50 years. In fact, only 19% of the non-CVD and 6% of the CVD donors
over 40 years were classified with a normal LCA or a so called non-progressive lesion type.
Fibrous calcified plaques (FCP), the consolidated remnants of earlier ruptured lesions, dom-
inated in both non-CVD and CVD donors. Estimates of the atherosclerosis burden (i.e. aver-
age lesion grade, proportion of FCPs, and average number of FCPs per cross-section) were
all higher in the CVD group (p<1.10−16, p<0.0001, and p<0.05, respectively).
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Conclusions
Dominance of consolidated FCP lesions in males over 40 and females over 50 years, show
that plaque ruptures in the left coronary artery are common. However, the majority of these
ruptures remain asymptomatic. This implies that the atherosclerotic process is repetitive. A
relative difference in disease burden between CVD and non-CVD donors supports the con-
cept that complications of atherosclerotic disease involve a stochastic element.
Introduction
Ischemic heart disease remains the leading cause of death worldwide.[1] While the successes
of preventive life-style and medical interventions for ischemic heart disease are almost unprec-
edented, achievable risk reductions remain below 40%.[2] Moreover, it has been pointed out
that the majority of ischemic events occur in persons currently not identified by risk profiling.
[3,4] Although these reservations may imply shortcomings in current risk profiling models
and management strategies, the high prevalence of residual disease may also reflect a degree of
randomness in the development of the thrombo-embolic complications of coronary athero-
sclerosis (viz. ischemic heart disease being stochastic rather than deterministic).[5,6] This lat-
ter scenario is supported by plateauing of the C-statistics for cardiovascular risk prediction
models at values between 0.75 and 0.80.[7–9]
Incident ischemic coronary events result from a complex sequence of events that involves ath-
erosclerotic lesion formation and destabilization as the initial provocative factor. Actual develop-
ment (or absence) of clinical manifestations relates to the occurrence or absence of thrombo-
embolic complications. Development of thrombo-embolic complications and its clinical conse-
quences reflect a complex interplay of pro- and anti-thrombotic factors, the fibrinolytic system,
ischemia times, (residual) coronary lumen size, tissue oxygen demand, pre-existing collateral vas-
cular networks etc.[10–12] In this context, we hypothesized that thrombo-embolic complications
of coronary atherosclerosis are stochastically determined, and that human coronary atheroscle-
rotic disease is a repetitive process that proceeds through multi-focal and asynchronous cycles of
plaque initiation, -progression, and -destabilization. In absence of a fatal thrombo-embolic com-
plication, plaque destabilization is followed by consolidation of the lesion.
The various aspects of the atherosclerotic process (viz. plaque initiation, -progression, and
-destabilization followed by lesion consolidation) are best appreciated by histology as only this
technique allows for assessment of the different stages of the disease. Discriminative plaque
characteristics are captured by the AHA consensus classification scheme.[13,14] This scheme
has been refined [15] (often referred to as the Virmani classification) in order to better mimic
the natural history of the disease. More specifically, this revised classification scheme covers all
distinct aspects of the atherosclerotic process (i.e. plaque initiation, -progression, and–destabi-
lization, possible thrombo-embolic complications, as well as the aspects of plaque healing and
scarring (lesion consolidation after destabilization (plaque rupture)).
We reasoned that if the assumption ‘that atherosclerosis reflects an asynchronous, repetitive
process with thrombo-embolic complications as a stochastic (lethal) element’ is correct, this
would translate in relative rather than in absolute differences in atherosclerotic lesion load in
patients dying from cardiovascular causes and those from non-cardiovascular causes, with accrual
of consolidated lesions [15] and a higher lesion burden [16] in the cardiovascular death group.
To test this hypothesis, we performed a systematic evaluation of the atherosclerotic load of
the left main coronary artery, a primary predilection place for atherosclerotic disease, of young
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and middle-aged deceased Dutch tissue donors who donated their heart for aortic valve pro-
curement. Two separate groups were created: one group dying from atherosclerosis-related
(cardiovascular) causes, and a second group of donors who died from non-atherosclerotic
related causes. The atherosclerosis load is evaluated and reported separately for each group.
Methods
Patients and tissue sampling
Use of the donor material for scientific purposes is approved by the Medical and Ethical Com-
mittee of the Leiden University Medical Center, The Netherlands. Sample collection and han-
dling was performed in accordance with the guidelines of the Medical and Ethical Committee
of the Leiden University Medical Center, and with the code of conduct of the Dutch Federa-
tion of Biomedical Scientific Societies. In all cases permission for transplantation orientated
research was given or permission was inherent to donation.
Due to national regulations, only data relevant for transplantation was available for research
(http://www.federa.org/codes-conduct). More specific information such as cholesterol or CRP
levels were not available for the donors. Information on smoking (history) relied on hetero-
anamnesis.
This study included data from 698 successive proximal left coronary artery (LCA) segments
from as many Dutch donors who donated their heart for aortic valve procurement in the
period 2011–2017. The age limit for aortic valve donation is 65 years, as such the maximum
age of individuals in the study is 65 years. Further main exclusion criteria for donation include
(a history of) malignancy, sepsis and/or risk of transferable disease (hepatitis, prions etc.), (sus-
pected) connective tissue disorders or vasculitis/myocarditis. Moreover, donation criteria
exclude men over 50 years with a history of diabetes, COPD or abdominal aortic aneurysm.
The LCA segments were collected during the aortic valve dissection. Valve procurement
was performed within 40hrs after death at the Euro Heart Valve Bank (Beverwijk, The Nether-
lands). In short: the aortic valves were carefully removed from the intact heart, freed from the
surrounding pericardial fat, and banked for transplantation. The surrounding pericardial fat
tissue containing a segment of the proximal LCA (approximately 2-3cm) was formaldehyde
fixed and used in this study. This collection procedure did not interfere with the actual valve
dissection or the pathological analysis of the heart necessary for the final release of the banked
valves.
Two study groups were created: a non-cardiovascular death (non-CVD) group and a car-
diovascular death (CVD) group. The non-CVD group included all donors whose cause of
death was not atherosclerosis-related (viz. suicide, high energy trauma, subarachnoid haemor-
rhage, subdural hematoma, venous thrombosis). The CVD group included all individuals who
died from atherosclerosis-related causes (viz. myocardial infarction, cerebrovascular accident).
Histological lesion classification.
The formaldehyde-fixed tissue was decalcified (Kristensen’s solution) in order to facilitate
proper sectioning. Decalcification does not interfere with (calcium) scoring, as histological
footprints of earlier calcium deposits remain present after the process of decalcification
(brown and dark purple deposits in Movat staining illustrated in Fig 1).
Coronary arteries were divided in consecutive 5mm segments. Each segment was paraffin
embedded, and 4μm sections were prepared for each individual segment. Movat pentachrome
staining was performed for each 5mm segment, and all segments were classified (revised classi-
fication of the American Heart Association (AHA) as proposed by Virmani et al. [15], Table 1
and Fig 2). Classification was performed by at least two experienced observers with no
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knowledge of the donor characteristics. Incongruent opinions were resolved in separate ses-
sions with a third attending observer.
For each donor, the section of the tissue segment showing the most advanced lesion type
was used in this study (reference-section). Many donors presented with multiple consolidated
end-stage lesions (fibrous calcified plaques (FCPs)) in the reference-section. These sections
were further sub-classified on basis of the sum of separate FCP lesions present in the refer-
ence-section (illustrated in Fig 1). Chronic occlusion [15, 16] was defined as coronary arteries
showing a full fibrotic occlusion of the lumen.
Statistical analysis
Statistical analysis was performed using SPSS 22 (IBM, Amsterdam, The Netherlands). The
Virmani atherosclerosis grading [15] used is a descriptive progressive score. In order to allow
Fig 1. Movat staining of a coronary artery cross section illustrating the foot prints of consolidated calcified lesions (purple-brown demarcations indicated by the
arrow in the enlarged insert), and the presence of multiple lesions within a single cross section. I: late fibro-atheroma (LFA) lesion (necrotic core covered by a fibrous
cap). II-V: indicating consolidated former lesions (fibrotic calcified plaque (FCP)) [15].
https://doi.org/10.1371/journal.pone.0207943.g001
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statistical evaluation of atherosclerosis progression and comparison of atherosclerosis burden
we reclassified the lesions types (Fig 2A–2C) in a progressive numeric score (normal = 1, adap-
tive intimal thickening = 2, intima xanthoma = 3. . ., one FCP lesion per cross section = 10, 2
FCP lesions per cross-section = 11, 3 FCP lesions per cross-section = 12, 4 FCP lesions per
cross-section = 13, 5 FCP lesions per cross-section = 14, chronic occlusion = 15). Numeric
scores were considered as a continuous variable, and associations conservatively estimated
through generalized estimating equations. P values below 0.05 were considered significant.
In order to avoid interpretation problems due to over-plotting, data points in the graphs
have been jittered. [17] Individual data is available in the supplemental data sheet.
Results
This study includes data for the proximal LCA of 698 aortic valve donors (376 men and 322
women). The 65-year upper age limit was dictated by the eligibility criteria for valve donation.
Donors were sub-classified on basis of their cause of death in a non-CVD group (n = 335) and
a group that died from atherosclerosis-related causes (CVD group, n = 363). Reportedly,
approximate 24% of all deaths (46.7% in the CVD group) were related to an acute myocardial
infarction. Three patients in the CVD-death group had an intracoronary stent in their LCA,
and could therefore not be graded. These individuals were excluded from the analysis.
Baseline characteristics for the two groups are provided in Table 2. Since young age is a
major confounder of cause-of-death (i.e. cardiovascular death is rare before the age of 35, and
young males dying from unnatural causes dominate in the younger aged deaths), characteris-
tics for individuals over 40 are also presented separately in Table 3.
In those over 40, the data for the CVD group showed a clear dominance of male sex
(p<1.10−7) and a slightly higher BMI (p< 0.02). Proportions of individuals treated for hyper-
cholesterolemia and/or hypertension were similar in the CVD and non-CVD group.
The age distribution of atherosclerosis (defined by most advanced lesion type present (grad-
ing summarized in Table 1 and illustrated in Fig 2)) for all individual LCAs is shown in Fig 3A
(non-CVD individuals) and Fig 3B (CVD individuals). Qualitative grading showed an
endemic presence of non-progressive atherosclerotic lesions (AIT and IX) and pathological
intimal thickening (Fig 3A and 3B) in individuals under 30. Advanced lesions were absent in
the younger donors.
Table 1. Adapted AHA classification schema for human atherosclerosis [15].
Normal (Norm) Thin intima, minimal presence of smooth muscle cells
Adaptive Intimal Thickening
(AIT)
Thickening of the intima, smooth muscle cells crossed the internal elastic lamina
Intima Xanthoma (IX) Adaptive Intimal Thickening + presence of foam cells
Pathological Intimal
Thickening (PIT)
Thickened intima with a structured lipid core
Early Fibro-atheroma (EFA) Thickened intima with a structured lipid core and small cholesterol crystals
Late Fibro-atheroma (LFA) Large confluent lipid core with large cholesterol crystals that is covered by a thick
collagenous cap
Thin Cap Fibro-atheroma
(TCFA)
Large confluent lipid core with large cholesterol crystals that is covered by a thin
(<65μm) collagenous cap
Ruptured Plaque (RP) Discontinuation (rupture) of the collagenous cap
Healed Rupture (HR) Coverage of the rupture lesion with proteoglycan/smooth muscle cell-rich matrix
Fibrous Calcified Plaque (FCP) A fibrotic, a-cellular lesion with one or multiple condensed, calcified remnants of
a necrotic core
https://doi.org/10.1371/journal.pone.0207943.t001
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For both groups, the age of 40 marks a transition after which the more advanced lesion
types become prominent (Fig 3A and 3B). This resulted in an endemic presence of progressive
atherosclerotic lesions in individuals over the age of 40 years. In fact, over the age of 40 only
19.1% (95% CI: 14.7–24.5%) in the non-CVD and 6.0% (95% CI: 4.0–9.0%) in the CVD group
was classified as having a normal LCA or a LCA with a non-progressive atherosclerotic lesion.
[15] Moreover, the consolidated (end-stage atherosclerotic disease) fibrous-calcified plaque
(FCP) lesion-type was absent in donors under 35, but was by far the most prevalent lesion type
in individuals aged 40 and over. In fact, the LCA of 65.1% (95% CI: 59.9–70.3%) of the CVD
donors and 35.0% (95% CI: 29.1–41.3%, p<0.0001) of the non-CVD donors was classified
with a FCP in the reference cross-section. Many donors presented with multiple FCP lesions
in the reference cross-section (Fig 1). The number of individual FCP lesions in the reference
cross-section of each donor is represented in Fig 3A and 3B. Total occlusion of the LCA was
observed in three donors: one acute fatal thrombotic total occlusion, and a chronic (fibrotic,
viz. non-lethal total occlusion) in two donors. The prevalence of so-called vulnerable (culprit)
lesions (i.e. thin cap fibro-atheroma (TCFA), ruptured plaque (RP) or healed rupture (HR))
was 3.5% (95% CI: 1.8–6.3%) in men and 1.6% (95% CI: 0.6–3.9%) in women over 40.
Discussion
This systematic, qualitative evaluation of coronary atherosclerosis burden of the proximal left
coronary artery of young and middle-aged tissue donors shows a relative rather than an abso-
lute difference in disease burden between individuals dying from cardiovascular- and those
dying from non-cardiovascular causes. Accumulation of consolidated FCP lesions in men over
Fig 2. Adapted AHA (Virmani) classification of coronary atherosclerotic lesions [15] (Movat stained coronary artery segments). (2-A) Normal and non-
progressive (reversible) lesions [15] Adaptive intimal thickening (AIT) is characterized by hyperplasia of the tunica intima (blue); intimal infiltration of macrophages
(black arrows) and presence of foam cells characterize intimal xanthoma (IX). (2-B) Progressive atherosclerotic lesions.[15] Pathological intimal thickening (PIT) is
hallmarked by a pre-necrotic lipid core, with or without surrounding infiltrated foam cells (black arrows). Early and late fibro-atheroma (EFA and LFA) are
characterized by a necrotic lipid core, cholesterol crystals, and an overlying thick collagen-rich (yellow/green) fibrous cap. Thin cap fibro-atheroma (TCFA) is
characterized by a thin fibrous cap, which precedes rupture (plaque rupture (PR)). Rupture is followed by a healing process with formation of a new proteoglycan/
cell rich cap (healed rupture (HR)). (2-C) Stabilized atherosclerotic lesions and acute total occlusion.[15,16] The healed rupture ultimately transforms into a scar, the
fibrotic calcified plaque (FCP) contains calcified remnants of the necrotic core. New lesions can develop on top of FCPs (neo-intima, blue), which can ultimately
result in stacked lesions. This may eventually cause accumulation of multiple lesions within one cross section (red arrows) and formation of a neo-intima overlying
the consolidated earlier lesions. Acute occlusion represents an example of a (fatal) thrombo-embolic acute full occlusion of the LCA.
https://doi.org/10.1371/journal.pone.0207943.g002
Table 2. Donor characteristics for the full cohort (A)). (mean [sd] or absolute number (proportion)). P-values are
for the non-CVD† vs. CVD cohorts.
Non CVD † CVD †
N 335 360
Sex (male) 44.8% 62.7% p<0.0001
Age (Years) 48.0 [13.7] 54.21 [7.5] p<1 10−15
BMI (kg/m2) 24.8 [3.9] 25.9 [3.1] p<0.0001
Cause of death
Trauma 98 (27.2%) -
Asphyxia 81 (24.2%) -
Pulmonary Embolism/ Dissection 42 (12.5%) -
Sub Arachnoid- or Subdural Hematoma 91 (27.2%) -
Metabolic 23 (6.9%) -
Myocardial Infarction - 163 (46.7%)
Cerebral Vascular Accident - 194 (54.3%)
https://doi.org/10.1371/journal.pone.0207943.t002
Qualitative evaluation of coronary atherosclerosis
PLOS ONE | https://doi.org/10.1371/journal.pone.0207943 November 27, 2018 7 / 13
40 and women over 45 implies that incident plaque rupture, and subsequent healing and scar-
ring is a common phenomenon.
This comparative qualitative study is performed on material from a unique and large bio-
bank of proximal LCAs from (deceased) Dutch donors who donated their heart for aortic
valve replacement procedures. The LCA is an established predilection place for (coronary) ath-
erosclerosis. In fact, intravascular ultrasound studies show a mild gradient with the higher ‘pla-
que burden’ for the more proximal aspects of the coronary arterial tree. [18, 19]
Multiple studies have shown that the manifestations and complications of atherosclerotic
disease essentially relate to the qualitative rather than quantitative (i.e. degree of occlusion)
aspects of the process. [20, 21] Accordingly, we applied a systematic histological evaluation
(‘grading’) as only this technique allows for a full appreciation of qualitative aspects of the ath-
erosclerotic process. [15] More specifically, atherosclerosis grading was performed for every 5
mm segment of each LCA using the Virmani classification. [15] This modification of the AHA
classification14 better incorporates the natural history of the atherosclerotic process; viz. plaque
initiation, lesion (lipid core) formation and -progression, plaque destabilization, and ultimate
rupture. In the absence of fatal complications, rupture is followed by plaque healing and lesion
consolidation. [15, 16] Consolidated lesions are characterized by a condensed, often calcified
remnant of the original lipid core, and a surrounding, a-cellular collagenous (fibrotic) matrix;
the ‘fibrous calcified plaque’ as described in the Virmani classification. [15]
Although the data from this evaluation confirms observations from earlier quantitative
reports showing that atherosclerosis manifests early in life, [22–28] this qualitative analysis
shows for young individuals (i.e. age below 40 years) that the process remains essentially lim-
ited to early lesion types (adaptive intimal thickening, intima xanthoma and pathological inti-
mal thickening), and that the more advanced lesions types are absent in young individuals.
Absence of advanced lesion types in young individuals in this cross-sectional study supports
the notion that the early lesion types can be non-progressive, yet finite conclusions can obvi-
ously only be drawn from prospective follow up studies.
Table 3. Donor characteristics for the individuals† over 40 years of age. (mean [sd] or absolute number (propor-
tion)). P-values are for the non-CVD vs. CVD cohorts.
N 249 350
Sex (male) 39.4% 62.6% p<1.10−7
BMI (kg/m2) 25.1 [4.0] 25.9 [3.1] p<0.01
(Treated) Hypertension 78 (25.5%) 125
(35.6%)
NS
Statin use 21 (7%) 42 (12%) NS
% individuals with non- progressive lesions 19.7% 6.3% p<0.0001
Mean lesion grade�) 6.23 (3.3) 8.67 (3.0) p<1.10−16
% individuals with consolidated lesion(s) present 35.0% 65.1% p<0.0001
Mean # consolidated lesions 1.44 [0.68] 1.63 [1.00] p<0.05
Mean age of patients with one or more consolidated lesions
Males 55.3 (6.1) 54.9 (5.0) NS
Females�� 59.3 (6.3) 58.2 (6.5) NS
† CVD: cardiovascular death
�) lesion types in the Virmani classification [15, 16] were reclassified in a progressive numeric score (normal = 1. . ., 1
FCP in the cross section = 10, 2 FCPs = 11 etc., chronic occlusion = 15). Individual lesion grading for all cases
including individuals <40 years of age is shown in Fig 3.
��) Females with at least one consolidated lesion significantly older than the males: non CVD group: P<0.004; CVD
group: P<0.0003.
https://doi.org/10.1371/journal.pone.0207943.t003
Qualitative evaluation of coronary atherosclerosis
PLOS ONE | https://doi.org/10.1371/journal.pone.0207943 November 27, 2018 8 / 13
Qualitative evaluation of coronary atherosclerosis
PLOS ONE | https://doi.org/10.1371/journal.pone.0207943 November 27, 2018 9 / 13
The age of 40 years marks a critical tipping point beyond which advanced atherosclerotic
lesion types become endemic. In fact, this study indicates dominance of the FCP lesion types
[15, 16] in the individuals dying from cardiovascular causes and, to a somewhat lesser extent,
in those dying from non-cardiovascular causes. Although this phenomenon obviously reflects
the stable, presumable (semi) permanent nature of these lesions, it also signals consolidation
(healing) of an earlier non-fatal plaque rupture. [15, 16] As such, the data implies that plaque
ruptures are rather common in individuals over 40, and often pass unnoticed.
The higher FCP load in CVD-death group supports the concept that thrombo-embolic
complications of coronary atherosclerosis involve a stochastic element. That is to say, each
bout of plaque rupture comes with a risk for a threatening thrombo-embolic complication,
and consequently the more plaque ruptures, the higher the chance of a fatal life-threatening
event. A further noteworthy observation was the common presence of multiple adjacent, or
even stacked FCP lesions in a single LCA cross-section. This observation implies that athero-
sclerosis is a repetitive process.
The data further indicates a low prevalence of classic, advanced atherosclerotic lesion types
(EFA and LFA) and vulnerable lesions. [15, 16] This implies that the process of atheroma for-
mation, -progression, and lesion destabilization is relatively rapid. This observation, that along
with the apparent repetitive character of the atherosclerotic process, and the putative stochastic
aspects of thrombo-embolic complications provide a rationale for the current focus shift from
plaque vulnerability to plaque burden as a superior ‘predictor’ for future ischemic events. [29]
Although the plaque burden itself does not relate to future ischemic events, it does reflect the
individual’s past and consequently the odds for a future event. [30]
It came to our attention that the apparent repetitive nature of the atherosclerotic process
with asynchronous cycles of atherosclerotic lesion initiation and evolution provides a rationale
for the observed delays in benefit reported for clinical cardiovascular risk management. [31,
32] In fact, both studies on lipid lowering (statins) [31] as well as those targeting inflammation
(Cantos trial) [32] show an approximate 12-month delay before a therapeutic benefit becomes
apparent. One could speculate that the main benefit of these interventions is a reduction in
lesion formation rather than on lesion progression and destabilization.
Limitations: this study is based on the proximal LCA segment collected during aortic valve
procurement for tissue donation. Consequently, information on other segments of the coro-
nary arterial tree is missing. The proportion of patients dying from stroke is higher than
expected, [33] an observation that is presumably secondary to the criteria for heart valve dona-
tion. As result of the capped age limit in donation guidelines, this study only includes data
from individuals dying before the age of 65. As such, results may not be representative for the
elderly population. Moreover, material in this biobank is from individuals who died from sud-
den death. A large proportion of whom without a medical history, hence without information
on cardiovascular risk factors including genetic predisposition. In those with a medical history,
only data for medication use and BMI was available. Available data on blood pressure is influ-
enced by the medical condition leading up to death. Lipid profiles and a reliable smoking his-
tory are not available. A more in-depth evaluation of those on pharmaceutical cardiovascular
risk management (anti-hypertensives and/or cholesterol lowering) is obviously obscured by
the varying levels of pharmaceutical cardiovascular risk management, and by confounding-by-
indication. As such no conclusions can be drawn from these parameters.
Fig 3. Age distribution for the most advanced lesion type present in the proximal left coronary artery .segment studied. Fig 3A: non-
cardiovascular death donors. Fig 3B: cardiovascular death donors. ‘+’ represent females and ‘o’ represent males. Data points have been
jittered [17] in order to avoid overlap.
https://doi.org/10.1371/journal.pone.0207943.g003
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For the younger individuals, a further bias may result from clinical competition between tis-
sue (valve), and organ (heart transplant) donation for the ‘healthier’ donors, and thus that
LCAs from healthier young donors are underrepresented. This will obviously not impact the
core conclusions of this study as these are essentially based on information from the donors
over the age of 40 years. Moreover, we consider the potential impact minimal as we observed
remarkable parallels between the atherosclerosis distribution in this LCA cohort, and our ear-
lier published data for the peri-renal artery aorta (a predilection location for human athero-
sclerosis). [34] Material for this evaluation was collected during organ procurement for kidney
transplantation, a context without competition between organ- and tissue donation, and less
stringent age restrictions.
In conclusion, this cohort of Dutch tissue donors shows that advanced atherosclerotic dis-
ease is endemic over the age of 40 (men) and 45 (women). Asymptomatic plaque ruptures
appear common, supporting the concept that thrombotic-embolic complications after plaque
rupture reflect a stochastic event.
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